The 2023 IDPHSB Center for HIV Prevention and Health Services Integrated Statewide Meeting: "Mobilizing Our Efforts for Outcomes-Based Success" took place virtually on Friday, November 3, 2023 from 9:00 AM to 4:30 PM Eastern.
This module examines three related non-pharmacological approaches to pain management. The module will discuss relevant benefits and risks associated with these therapies. Additionally, the module provides health professionals with the ability to integrate these approaches into their practice and knowledge of which patients are good candidates for these types of pain treatments.
This Module is addressing the aging population of people living with HIV in the Ryan White community with a look at Washington DC. In the presentation, you will note aging, older than 50, and older than 55 are used interchangeably. In some cases that data looked at a populations over 55.
Faculty: Jim Williams, B.A.
Contact Information: HAHSTACBAPrograms@dc.gov
Young people living with HIV (PLWHIV) are at an increased risk for developing mental health disorders than people not living with HIV. PLWHIV commonly internalize negative attitudes and beliefs resulting from widespread HIV stigma, which leads to poor mental health outcomes and difficulty medically managing HIV. Challenges in mental health can negatively affect engagement in medical care and adherence to medical treatment.
This module aims to increase the audience’s understanding of mental health challenges of children, adolescents, and young adults living with HIV and to provide ways to address their particular needs and promote overall physical and mental health
Start Date: 7/27/2023After completing this activity, the participant should be better able to:
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high-quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:
The faculty presenters have nothing to disclose.
The PIM planners and others have nothing to disclose. The HealthHIV planners and others have nothing to disclose.
In
support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and HealthHIV. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical
Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Postgraduate Institute for Medicine has been authorized by the American Academy
of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their
participation.
As a Jointly Accredited Organization, Postgraduate Institute
for Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial
regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Postgraduate Institute for Medicine maintains responsibility for this course. Social workers completing this
course receive 1.0 Clinical continuing education credits.
This course is jointly provided by Postgraduate Institute for Medicine (PIM) and HealthHIV.
Please review the content below at your own pace.
NOTE: If you seek continuing education credits (CEUs) from PIM after completing the module, you will go to their website and complete a post-course check and an evaluation. If you will not seek credits, you will not need to take a post-course check, but please complete the non-credit evaluation at the end of the module. Whether or not you seek credits, you do not need to take a pre-course check and can go straight to the presentation.
Release Date: August 24, 2023
Expiration Date: August 24, 2024
UAN: JA4008162-9999-23-292-L02-P
This activity is intended for physicians, pharmacists, registered nurses, PAs, psychologists, social workers and other healthcare providers engaged in the care of patients with HIV.
After completing this activity, the participant should be better able to:
Valerie Wojciechowicz
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:
The faculty presenter has nothing to disclose.
The PIM planners and others have nothing to disclose. The HealthHIV planners and others have nothing to disclose.
In
support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and HealthHIV. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical
Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hours.
Postgraduate Institute for Medicine designates this continuing education activity for 1.0 contact hour(s) (0.1 CEUs) of the Accreditation Council for Pharmacy Education.
Postgraduate Institute for Medicine has been authorized by the American Academy
of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their
participation.
As a Jointly Accredited Organization, Postgraduate Institute
for Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial
regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Postgraduate Institute for Medicine maintains responsibility for this course. Social workers completing this
course receive 1.0 Clinical continuing education credits.
Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.
Credit Designation: This program offers 1 continuing education credits for psychologists.
This activity was planned by and for
the healthcare team, and learners will receive 1 Interprofessional Continuing Education (IPCE) credit for learning and change.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
There are gaps in understanding the changing demographics of people with HIV, as well as gaps in understanding the impact of aging on co-morbidities in people with HIV. This webinar reviews the current epidemiology of HIV, identifies key points of HIV and aging, and discusses the impact of the aging population and co-morbidities on HIV.
Faculty: Dr. John Hogan
Please review the content below at your own pace.
**NOTE: This course is no longer offering CE credits.**
This session provides a non-clinical view of harm reduction, with a particular focus on its intersection with aging. The presenter draws upon her lived experiences from layered perspectives on substance use, mental well-being, HIV, and aging to review models and techniques supporting informed decision-making to define one's personal view of harm reduction. The presentation includes a discussion of some behaviors that support as well as hinder smooth sustainability across one's lifespan.
Learning Objectives:
At the end of this webinar, you will be able to:
Faculty: Linda Scruggs, MHS, LPC, SME
NOTE: This module does NOT offer continuing education credits.
By 2030, nearly 75% of all people living with HIV (PWH) in the US will be aged 50 and older. 84% will most likely have at least one (1) additional comorbidity; 28% will have three (3)—compared with only 19% of those not living with HIV. And while older PWH have shown higher rates of service engagement compared with their younger counterparts, the successes prolonging “physical” health is undermining other aspects of successful aging with HIV and their interventions. Together with community leaders, provider participants will discuss and frame their shared experience conversations into adaptive and innovative recommendations and evidence-based interventions that reduce disability and improve service delivery for PAWH.
With improved access to antiretrovirals, people are now aging and living longer with HIV (PAWH). While the care cascade highlights our shared medical successes, it doesn’t show the entire picture of the true “costs” of graying of HIV. In fact, health systems often overlook the underlying problem of HIV’s distinctiveness—especially as we age. In an increasingly bio-medicalized context of care delivery, what does successful aging with HIV look like? This roundtable brings together people living and aging with HIV (15 years or more) to review and reflect upon the current capacity and future constraints of the HIV and aging care and prevention services sectors, and the discrete needs that follow.
Tez Anderson, Let’s Kick ASS
Jon Appelbaum, Florida State University College of Medicine
Scott Bertani, Director of Advocacy for HealthHIV
Michelle Lopez, Healthy Aging Specialist at GMHC
Donna Sweet, University of Kansas School of Medicine
Val Wojciechowicz, Medical Peer Program Manager at Community AIDS Network/CAN Community Health
Visit sync2021.org/credits for information on claiming and receiving CME/CE credits for this session.
TelePrEP is a service that provides pre-exposure prophylaxis (PrEP) medication to individuals at risk of contracting HIV via remote telemedicine appointments. It allows patients to receive PrEP medication and support from a healthcare provider without having to visit a clinic in person, making it more convenient and accessible.
TelePrEP in Practice is a webinar that covers the benefits of telePrEP, as well as strategies and best practices for integrating telePrEP into your organization's services.
Release Date: May 17, 2023
Expiration Date: May 17, 2024
UAN# JA4008162-9999-23-231-H02-P
After completing this activity, the participant should be better able to:
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high-quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:
The faculty presenters have nothing to disclose.
The PIM planners and others have nothing to disclose. The HealthHIV planners and others have nothing to disclose.
In
support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and HealthHIV. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical
Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Postgraduate Institute for Medicine has been authorized by the American Academy
of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their
participation.
As a Jointly Accredited Organization, Postgraduate Institute
for Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial
regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Postgraduate Institute for Medicine maintains responsibility for this course. Social workers completing this
course receive 1.0 Clinical continuing education credits.
The Testing and Linkage to Care curriculum is composed of a self-paced elearning course and 5 self-paced webinars on HIV testing topics. Learners must complete the self-paced course and all four self-paced webinars to complete the curriculum and enroll in the HIV Testing Skills Assessment.
This course is only available for learners/testers who are based in Maryland. If you believe you should be able to access the course and cannot please email eLearning@healthhiv.org.
Harm reduction meets people wherever they are ready to begin their positive change journeys, supports the full range of positive change goals and emphasizes empowerment and collaboration between therapist and client. Drawing on relational, psychodynamic, cognitive-behavioral and mindfulness therapies, IHRP techniques are uniquely tailored to each person. A central focus on therapeutic alliance and relationship creates a safe context in which to clarify the meanings and functions of risky and addictive behavior, enhance self-regulation and develop alternative healthier, self-affirming solutions. Tatarsky will discuss harm reduction’s core principles, the limitations of traditional disease model based abstinence-only treatment, IHRP’s clinical rationale, supporting biopsychosocial theory and seven therapeutic tasks.
Faculty: Andrew Tatarsky, PhD
Original Recording Date: 8/29/22
NOTE: This module does NOT award credits.
This course is jointly provided by Postgraduate Institute for Medicine and HealthHIV.
Please review the content below at your own pace.
Release Date: 9/25/23
Expiration Date: 9/25/24
UAN: JA4008162-9999-23-326-L02-P
This activity is intended for physicians, pharmacists, registered nurses, PAs, psychologists, social workers and other healthcare providers engaged in the care of patients with HIV.
After completing this activity, the participant should be better able to:
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:
Dr. Mark Sulkowski disclosed that he had received research grants from Janssen, Vir, and AbbVie, over the course of his work at Johns Hopkins, that he had received consulting fees from AbbVie, Aligos, Atea, Gilead, Precision Bio, GSK, and Virion, pursuant to serving as a Scientific Advisory Board member related to HBV, SARS-CoV-2 and HCV, that he had received personal payments related to work for Gilead and Immunocore, on DSMB related to HIV and HBV, and that he had received personal payments for his role on Journal Viral Hepatitis as the American Editor.
The PIM planners and others have nothing to disclose. The HealthHIV planners and others have nothing to disclose.
In
support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and HealthHIV. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical
Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hours.
Postgraduate Institute for Medicine designates this continuing education activity for 1.0 contact hour(s) (0.1 CEUs) of the Accreditation Council for Pharmacy Education.
Postgraduate Institute for Medicine has been authorized by the American Academy
of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their
participation.
As a Jointly Accredited Organization, Postgraduate Institute
for Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial
regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Postgraduate Institute for Medicine maintains responsibility for this course. Social workers completing this
course receive 1.0 Clinical continuing education credits.
Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.
Credit Designation: This program offers 1 continuing education credits for psychologists.
This activity was planned by and for the
healthcare team, and learners will receive 1 Interprofessional Continuing Education (IPCE) credit for learning and change.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
This webinar will provide participants with an overview of how to apply harm reduction principles for people who use drugs (PWUD) to the context of sexual health and relationships. The faculty will review how practicing harm reduction within sexual relationships between PWUD can reduce the risk of HIV, HCV, and other sexually transmissible infections. Participants will learn how to identify possible sexual risk scenarios for their clients, as well as how to discuss sexual harm reduction with clients with the goal of enhancing and maintaining overall health.
Learning Objectives:
At the end of this webinar, you will be able to:
Faculty:
Mark Robinson, Regional Syringe Service Program Manager for Family and Medical Counseling Service, Inc.
Monica S. Ruiz, PhD, MPH is an Associate Professor in the Department of Prevention and Community Health, Milken Institute School of Public Health, George Washington University (GWU)
Integrating biomedical interventions into practice is a key component of ending the HIV epidemic. Providers must communicate effectively with clients to inform them of scientifically-supported interventions, ensuring client understanding and addressing client concerns. This session will cover the 10 most common myths about PrEP, discuss a PrEP patient survey, and highlight several PrEP marketing efforts to engage clients. Identify the 10 most common myths preventing PrEP uptake in the U.S. Emphasize need to be fact-based and data-driven in one's communication with their patients and communities Discuss the PrEP program at the Virginia Department of Health Discuss the results and implications of the PrEP Patient Survey Describe best strategies for reaching specific communities (MSM, African-American, Latinx, trans, cis-gender female). Discuss incorporating humor and sex-positivity into marketing collateral
Learning Objectives:
This course is jointly provided by Postgraduate Institute for Medicine and HealthHIV.
Please review the content below at your own pace.
Release Date: May 30, 2023
Expiration Date: May 30, 2024
UAN: JA4008162-9999-23-233-L02-P
This activity is intended for physicians, pharmacists, registered nurses, PAs, psychologists, social workers and other healthcare providers engaged in the care of patients with HIV.
After completing this activity, the participant should be better able to:
Tyris D. Ford, DNP, NP-C, FNP-BC, AAHIVS
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:
The faculty presenter has nothing to disclose.
The PIM planners and others have nothing to disclose. The HealthHIV planners and others have nothing to disclose.
In
support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and HealthHIV. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical
Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hours.
Postgraduate Institute for Medicine designates this continuing education activity for 1.0 contact hour(s) (0.1 CEUs) of the Accreditation Council for Pharmacy Education.
Postgraduate Institute for Medicine has been authorized by the American Academy
of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their
participation.
As a Jointly Accredited Organization, Postgraduate Institute
for Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial
regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Postgraduate Institute for Medicine maintains responsibility for this course. Social workers completing this
course receive 1.0 Clinical continuing education credits.
Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.
Credit Designation: This program offers 1 continuing education credits for psychologists.
This activity was planned by and for the
healthcare team, and learners will receive 1 Interprofessional Continuing Education (IPCE) credit for learning and change.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
This webinar seamlessly combines theory and practice to empower participants with the essentials of outreach and secondary exchange. Delve into the significance of these approaches and the common barriers faced in their implementation. Discover highly effective strategies for outreach, recruitment, and engagement. Recognize the indispensable role of People Who Use Lived Experience (PWLE) in all aspects of Syringe Services Programs (SSPs). Additionally, gain valuable insights into available SSP resources in the DC area, ensuring comprehensive and inclusive care provision.
Learning Objectives:
Upon completion of this webinar, participants will be able to:
Faculty: Carolina Diaz, ACR Health and Elizabeth Wright, ACR Health
NOTE: This module does NOT offer continuing education credits.
This webinar will provide participants with an overview of the essential components of budgeting and fiscal health for Maryland providers.
Learning Objectives
At the conclusion of this session, you will be able to:
Explain why budgeting is important.
Identify the common types of budgets (operating budget and capital budget).
Describe budget components (revenue and income).
Create a contingency plan.
Identify bookkeeping best practices.
Develop budget justification.
| |||
This webinar will provide participants insights and strategies for engaging stakeholder organizations. Faculty will discuss how to identify stakeholders, develop long-lasting and mutually-beneficial partnerships, and work in sync to uplift the communities you serve.
Faculty: Kenya Hutton, Deputy Director, Center for Black Equity
Learning Objectives:
Release Date: May 1, 2024
Note: Continuing education credits are not available for this webinar.
This webinar is tailored for healthcare professionals and their supporters seeking to optimize Pre-Exposure Prophylaxis (PrEP) implementation. This session delves into identifying ideal PrEP candidates, linking and retaining clients effectively, and addressing prevalent barriers to PrEP access. Attendees will gain practical insights and strategies to enhance their PrEP navigation skills, ultimately contributing to more effective HIV prevention efforts
Release Date: January 24, 2024
Expiration Date: January 24, 2025
UAN: JA4008162-9999-23-110-H02-PThis activity is intended for physicians, pharmacists, registered nurses, PAs, psychologists, social workers and other healthcare providers engaged in the care of patients with HIV.
After completing this activity, the participant should be better able to:
Dr. Immerine Monet Ouwinga, MD, Board Certified Family Medicine, CCI Greenway Program and Medical Director of Title X
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:
The faculty presenter has nothing to disclose.
The PIM planners and others have nothing to disclose. The HealthHIV planners and others have nothing to disclose.
In
support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and HealthHIV. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical
Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
TThe maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hours.
Postgraduate Institute for Medicine designates this continuing education activity for 1.0 contact hour(s) (0. 10 CEUs) of the Accreditation Council for Pharmacy Education.
Postgraduate Institute for Medicine has been authorized by the American Academy
of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their
participation.
As a Jointly Accredited Organization, Postgraduate Institute
for Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial
regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Postgraduate Institute for Medicine maintains responsibility for this course. Social workers completing this
course receive 1.0 Clinical continuing education credits.
Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.
Credit Designation: This program offers 1.0 continuing education credits for psychologists.
This activity was planned by and for
the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credit for learning and change.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
